José L. Leiva-Pons
Autonomous University of San Luis Potosí(MX)
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes, Coronary Interventions and Diagnostics, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome(2011)996 cited
- → Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization(2012)865 cited
- → Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease(2017)781 cited
- → Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial(2013)109 cited
- → Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial(2005)71 cited
- → Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention(2019)69 cited
- → Stroke in Patients With Peripheral Artery Disease(2019)53 cited
- → Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial(2015)36 cited
- → Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry(2019)10 cited
- → Management of Acute Coronary Syndromes in Mexico(2009)5 cited